The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03425838
Recruitment Status : Active, not recruiting
First Posted : February 8, 2018
Last Update Posted : August 18, 2023
Information provided by (Responsible Party):
Borstkanker Onderzoek Groep

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : March 6, 2023
Estimated Study Completion Date : December 2025